+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Therapy Market - Global Forecast 2026-2032- Product Image
Cell Therapy Market - Global Forecast 2026-2032- Product Image
New

Cell Therapy Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4989916
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cell therapy market continues to transform with overlapping advances in technology, regulation, and commercialization. Senior decision-makers are required to navigate an increasingly complex landscape where strategic adaptation is vital for successful therapeutic and operational outcomes.

Market Snapshot: Cell Therapy Market Growth and Trends

The cell therapy market grew from USD 10.54 billion in 2025 to USD 11.58 billion in 2026, with an expected CAGR of 11.42%, reaching USD 22.50 billion by 2032. This robust trajectory is driven by a combination of scientific innovation, evolving regulatory frameworks, and elevated investments in translational infrastructure. As the sector expands, strategic priorities are evolving, with greater participation from biopharma companies, academic institutions, and service providers committed to developing clinically differentiated and scalable cell-based therapeutics.

Scope & Segmentation

  • Cell Types: The market divides between non-stem cells, such as CAR-T, dendritic, and NK cells, and various stem cells, including embryonic, hematopoietic, and mesenchymal, each with specific regulatory, sourcing, and differentiation needs.
  • Therapy Models: Both autologous approaches, focusing on individualized patient care, and allogeneic models, designed for scalable off-the-shelf therapies, shape commercial decisions and operational considerations.
  • Mode of Administration: Delivery routes—intramuscular, intratumoral, and intravenous—have distinct safety requirements, location demands, and personnel qualifications, influencing implementation at different points of care.
  • Clinical Applications: Market segmentation covers autoimmune disorders, oncology, infectious diseases, and regenerative medicine, each requiring tailored evidence generation strategies and unique clinical endpoints.
  • End-User Profiles: Academic and research institutions, hospitals, clinics, commercial laboratories, and specialized service organizations each drive adoption, resource needs, and differentiated operations across the value chain.
  • Geographical Regions: The Americas, Europe/Middle East/Africa, and Asia-Pacific define market dynamics through varied regulatory oversight, reimbursement policies, and manufacturing strengths.
  • Technology Platforms: Innovations include gene editing, advanced CAR constructs, process automation, and standardized potency assays, enhancing consistency and enabling scalable production across therapy types.

Key Takeaways

  • Recent advances in bioengineering and automation are expediting clinical translation while raising consistency standards for cellular products.
  • Early coordination between clinical development, manufacturing, and commercialization is now essential to meet regulatory demands and minimize operational risk.
  • Strategic collaborations with biotech firms, academic centers, and contract manufacturing organizations are expanding market access and specialist knowledge.
  • Proactive regional supply chain planning, informed by evolving reimbursement strategies, is critical in addressing logistical and regulatory challenges across global markets.
  • Value assessment models, including outcome-based contracts and real-world evidence, are reshaping negotiation approaches with payers for higher-cost therapies.
  • Segmenting by cell type, therapy model, delivery method, clinical application, and end-user profile enables companies to prioritize development and optimize resources in this dynamic environment.

Tariff Impact on Global Supply Chains

Recent tariff measures in the United States have introduced additional complexity to global cell therapy supply chains by affecting procurement costs and sourcing patterns for critical components. Developers are adopting regionalized and hybrid supply strategies, emphasizing supplier contract reviews, risk management, and supply chain monitoring to ensure continuity and regulatory compliance. These steps help maintain development timelines and support ongoing innovation.

Methodology & Data Sources

This report uses a mixed-methods framework, drawing on primary interviews with translational researchers, engineers, regulatory and commercial leaders, and review of scientific and regulatory literature. Analytical techniques include thematic coding, comparative regulatory scrutiny, and supply chain analysis. Findings are verified through triangulation for transparency and actionable insight.

Why This Report Matters

  • Provides senior decision-makers with frameworks to coordinate clinical, operational, and commercial initiatives, reducing execution risk and accelerating project success.
  • Equips procurement and operations teams to adapt supply strategies amid shifting tariff regimes and regulatory requirements.
  • Supports investment planning and strategic partnerships by mapping opportunities across all cell therapy market segments and key geographies.

Conclusion

Meeting the demands of the cell therapy market requires integrated strategy, operational flexibility, and a focus on measurable value. Early collaboration across functions positions organizations to capture new therapeutic opportunities and foster long-term competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cell Therapy Market, by Type
8.1. Non-stem Cells
8.1.1. CAR-T Cells
8.1.2. Dendritic Cells
8.1.3. NK Cells
8.2. Stem Cells
8.2.1. Embryonic Stem Cells
8.2.2. Hematopoietic Stem Cell
8.2.3. Mesenchymal Stem Cell
9. Cell Therapy Market, by Therapy Type
9.1. Allogenic
9.2. Autologous
10. Cell Therapy Market, by Mode of Administration
10.1. Intramuscular
10.2. Intratumoral
10.3. Intravenous
11. Cell Therapy Market, by Application
11.1. Autoimmune Disorders
11.1.1. Multiple Sclerosis
11.1.2. Rheumatoid Arthritis
11.2. Cancer Treatment
11.2.1. Hematologic Malignancies
11.2.2. Solid Tumors
11.3. Infectious Diseases
11.3.1. Bacterial Infections
11.3.2. Viral Infections
11.4. Regenerative Medicine
12. Cell Therapy Market, by End User
12.1. Academic & Research Institutes
12.2. Clinics
12.3. Commercial Laboratories
12.4. Hospitals
13. Cell Therapy Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Cell Therapy Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Cell Therapy Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Cell Therapy Market
17. China Cell Therapy Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Anterogen Co., Ltd.
18.6. Astellas Pharma Inc.
18.7. Athersys, Inc.
18.8. BioNTech SE
18.9. Bristol-Myers Squibb Company
18.10. Castle Creek Biosciences, Inc.
18.11. Catalent, Inc.
18.12. FUJIFILM Holdings Corporation
18.13. Gilead Sciences, Inc.
18.14. JCR Pharmaceuticals Co., Ltd.
18.15. Kolon TissueGene, Inc.
18.16. Lonza Group Ltd.
18.17. Medipost Co., Ltd.
18.18. Mesoblast Ltd.
18.19. Novartis AG
18.20. NuVasive, Inc.
18.21. Pfizer Inc.
18.22. Sartorius AG
18.23. Stemedica Cell Technologies, Inc.
18.24. Stempeutics Research Pvt. Ltd.
18.25. Takeda Pharmaceutical Company Limited
18.26. TegoScience
18.27. Thermo Fisher Scientific, Inc.
18.28. Vericel Corporation
List of Figures
FIGURE 1. GLOBAL CELL THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CELL THERAPY MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CELL THERAPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CELL THERAPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CELL THERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CELL THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CELL THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CELL THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CELL THERAPY MARKET SIZE, BY CAR-T CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CELL THERAPY MARKET SIZE, BY CAR-T CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CELL THERAPY MARKET SIZE, BY CAR-T CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CELL THERAPY MARKET SIZE, BY DENDRITIC CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CELL THERAPY MARKET SIZE, BY DENDRITIC CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CELL THERAPY MARKET SIZE, BY DENDRITIC CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CELL THERAPY MARKET SIZE, BY NK CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CELL THERAPY MARKET SIZE, BY NK CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CELL THERAPY MARKET SIZE, BY NK CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CELL THERAPY MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CELL THERAPY MARKET SIZE, BY EMBRYONIC STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CELL THERAPY MARKET SIZE, BY EMBRYONIC STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CELL THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELL, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CELL THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CELL THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELL, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CELL THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CELL THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CELL THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CELL THERAPY MARKET SIZE, BY INTRATUMORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CELL THERAPY MARKET SIZE, BY INTRATUMORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CELL THERAPY MARKET SIZE, BY INTRATUMORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CELL THERAPY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CELL THERAPY MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CELL THERAPY MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CELL THERAPY MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CELL THERAPY MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CELL THERAPY MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CELL THERAPY MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CELL THERAPY MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CELL THERAPY MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CELL THERAPY MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CELL THERAPY MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CELL THERAPY MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CELL THERAPY MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CELL THERAPY MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CELL THERAPY MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CELL THERAPY MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CELL THERAPY MARKET SIZE, BY BACTERIAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CELL THERAPY MARKET SIZE, BY BACTERIAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CELL THERAPY MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CELL THERAPY MARKET SIZE, BY VIRAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CELL THERAPY MARKET SIZE, BY VIRAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CELL THERAPY MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CELL THERAPY MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CELL THERAPY MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CELL THERAPY MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CELL THERAPY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CELL THERAPY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CELL THERAPY MARKET SIZE, BY COMMERCIAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CELL THERAPY MARKET SIZE, BY COMMERCIAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CELL THERAPY MARKET SIZE, BY COMMERCIAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS CELL THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. EUROPE CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. EUROPE CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPE CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 141. EUROPE CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 142. EUROPE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 143. EUROPE CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 144. EUROPE CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. EUROPE CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 146. EUROPE CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 147. EUROPE CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 148. EUROPE CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. AFRICA CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 162. AFRICA CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 163. AFRICA CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 164. AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 165. AFRICA CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 166. AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. AFRICA CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 168. AFRICA CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 169. AFRICA CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 170. AFRICA CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL CELL THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. ASEAN CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. ASEAN CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 185. ASEAN CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 186. ASEAN CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 187. ASEAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 188. ASEAN CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 189. ASEAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. ASEAN CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 191. ASEAN CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 192. ASEAN CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 193. ASEAN CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. GCC CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. GCC CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 196. GCC CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 197. GCC CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 198. GCC CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 199. GCC CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 200. GCC CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. GCC CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 202. GCC CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 203. GCC CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 204. GCC CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. BRICS CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. BRICS CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 218. BRICS CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 219. BRICS CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 220. BRICS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 221. BRICS CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 222. BRICS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 223. BRICS CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 224. BRICS CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 225. BRICS CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 226. BRICS CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. G7 CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. G7 CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 229. G7 CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 230. G7 CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 231. G7 CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 232. G7 CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 233. G7 CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. G7 CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 235. G7 CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 236. G7 CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 237. G7 CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 238. NATO CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 239. NATO CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 240. NATO CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 241. NATO CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 242. NATO CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 243. NATO CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 244. NATO CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 245. NATO CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 246. NATO CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 247. NATO CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 248. NATO CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 249. GLOBAL CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES CELL THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 252. UNITED STATES CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 254. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 255. UNITED STATES CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 257. UNITED STATES CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 258. UNITED STATES CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. CHINA CELL THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 262. CHINA CELL THERAPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 263. CHINA CELL THERAPY MARKET SIZE, BY NON-STEM CELLS, 2018-2032 (USD MILLION)
TABLE 264. CHINA CELL THERAPY MARKET SIZE, BY STEM CELLS, 2018-2032 (USD MILLION)
TABLE 265. CHINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 266. CHINA CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 267. CHINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 268. CHINA CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 269. CHINA CELL THERAPY MARKET SIZE, BY CANCER TREATMENT, 2018-2032 (USD MILLION)
TABLE 270. CHINA CELL THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 271. CHINA CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cell Therapy market report include:
  • Anterogen Co., Ltd.
  • Astellas Pharma Inc.
  • Athersys, Inc.
  • BioNTech SE
  • Bristol-Myers Squibb Company
  • Castle Creek Biosciences, Inc.
  • Catalent, Inc.
  • FUJIFILM Holdings Corporation
  • Gilead Sciences, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Kolon TissueGene, Inc.
  • Lonza Group Ltd.
  • Medipost Co., Ltd.
  • Mesoblast Ltd.
  • Novartis AG
  • NuVasive, Inc.
  • Pfizer Inc.
  • Sartorius AG
  • Stemedica Cell Technologies, Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takeda Pharmaceutical Company Limited
  • TegoScience
  • Thermo Fisher Scientific, Inc.
  • Vericel Corporation

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 11.58 Billion
Forecasted Market Value ( USD ) by 2032 $ 22.5 Billion
Compound Annual Growth Rate11.4%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Cell Therapy Market Report 2025 - Product Image

Cell Therapy Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Cell Therapy Market Size, Share, Trends and Forecast by Cell Type, Therapy Type, Therapeutic Area, End User, and Region, 2025-2033 - Product Image

Cell Therapy Market Size, Share, Trends and Forecast by Cell Type, Therapy Type, Therapeutic Area, End User, and Region, 2025-2033

  • Report
  • 138 Pages
  • Global
From
Cell therapy platform Market - Global Forecast 2025-2030 - Product Image

Cell therapy platform Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Cell Therapy Biomanufacturing Market - Global Forecast 2025-2030 - Product Image

Cell Therapy Biomanufacturing Market - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Autologous Cell Therapy Market Report 2025 - Product Image

Autologous Cell Therapy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.